Mylan $60 Million Securities Settlement — If You Bought Mylan Stock (MYL) Between 2016 and 2019, You Could Get Paid (File by July 10, 2026)
By Steve Levine
Published: March 16, 2026
Settlement Fund: $60,000,000
Estimated Per Share: ~$0.11 per eligible share (before fees)
Claim Deadline: July 10, 2026
What Is This Settlement About?
If you bought stock in Mylan — the pharmaceutical company best known for making the EpiPen — at any point between February 2016 and May 2019, you may be owed money from a $60 million class action settlement. Here is what happened and what it means for you, in plain English.What Is Mylan?
Mylan N.V. was one of the largest generic and specialty pharmaceutical companies in the world. If you have ever used a generic prescription drug, there is a good chance it was made by Mylan. The company was best known for manufacturing the EpiPen — the emergency epinephrine injector used by millions of people with severe allergies. Mylan also made hundreds of other generic medications, from blood pressure drugs to antibiotics to HIV treatments.During the time period covered by this settlement, Mylan's stock traded on the NASDAQ stock exchange under the ticker symbol MYL. If you owned shares through a brokerage account, a retirement account like an IRA or 401(k), or any other investment account, you may have held Mylan stock.
After the class period ended, Mylan merged with Upjohn — a division of Pfizer — in November 2020 to form a new company called Viatris (NASDAQ: VTRS). If you held Mylan stock through the merger, your shares were converted to Viatris shares.
What Is a Securities Class Action?
If you are not familiar with how securities class actions work, here is the basic idea. When you buy stock in a company, you are relying on the company's public statements — earnings reports, press releases, SEC filings — to be accurate. Federal securities laws require companies to tell the truth about their business. If a company or its executives make false or misleading statements that artificially inflate the stock price, and you buy stock at that inflated price, you lose money when the truth comes out and the stock drops. A securities class action is a lawsuit filed on behalf of all the investors who were harmed by those misrepresentations. Instead of each investor filing a separate lawsuit, one lawsuit covers everyone.A settlement means the company agrees to pay a sum of money to compensate those investors rather than risk a trial. The money is distributed proportionally based on when you bought, how many shares you held, and when (or if) you sold.
What Did Mylan Allegedly Do Wrong?
The lawsuit alleged that Mylan and three of its top executives — CEO Heather Bresch, President Rajiv Malik, and CFO Kenneth Parks — made false and misleading statements about FDA inspections and regulatory compliance problems at Mylan's manufacturing facilities around the world.In plain terms, the FDA inspects pharmaceutical manufacturing plants to make sure drugs are being made safely and correctly. When problems are found, the FDA issues compliance notices (such as warning letters or Form 483 observations). The lawsuit claimed Mylan's executives downplayed or concealed the severity of these FDA findings, making investors believe the company's manufacturing operations were in better shape than they actually were. This allegedly kept Mylan's stock price artificially high.
When the truth came out through a series of disclosures in 2018 and 2019 — on June 27, 2018, August 8, 2018, February 26, 2019, and May 7, 2019 — Mylan's stock price dropped significantly. Investors who bought shares at the inflated prices lost money.
Mylan denied all allegations. The court did not decide who was right. The parties agreed to settle for $60 million after a mediation session in December 2025.
Do I Qualify?
You qualify if you purchased or otherwise acquired publicly traded common stock of Mylan N.V. (NASDAQ: MYL) between February 16, 2016 and May 7, 2019 (inclusive) and were damaged as a result.To receive any payment, you must have held your shares through at least one of the corrective disclosure dates — June 27, 2018, August 8, 2018, February 26, 2019, or May 7, 2019. If you bought and sold all your Mylan stock before June 27, 2018, your recognized loss is zero.
This includes shares held in brokerage accounts, retirement accounts (IRAs, 401(k)s), and any other investment accounts. If you held Mylan stock through an employer retirement plan (ERISA plan), only shares purchased outside of that plan are eligible — the plan's trustees may file separately for shares held within the plan.
How Much Money Will I Get?
The total settlement fund is $60 million. After deductions for attorneys' fees (up to 25% of the fund), litigation expenses (up to $500,000), administration costs, and taxes, the remaining net settlement fund is distributed to claimants based on a formula that considers when you bought, how many shares you held, and when you sold.The estimated average recovery is approximately $0.11 per eligible share before fee deductions. Your actual payment could be higher or lower depending on your specific transactions and how many claims are filed.
If your calculated distribution amount is less than $10.00, no payment will be made.
How Do I File a Claim?
You must submit a claim form with supporting documentation showing your Mylan stock transactions during the class period. This means brokerage statements, trade confirmations, or similar records showing the dates you bought and sold Mylan shares and the prices you paid.Claims can be submitted online at the settlement website or by mail. The deadline is July 10, 2026.
Keep in mind: the settlement administrator does not have your transaction records. You must provide them yourself. If you no longer have your brokerage statements, contact your broker or financial institution to request copies.
What Are the Important Dates?
Claim Deadline: July 10, 2026
Opt-Out Deadline: May 15, 2026
Objection Deadline: May 15, 2026
Final Approval Hearing: June 15, 2026 at 10:00 AM ET (via Zoom)
Class Period: February 16, 2016 – May 7, 2019
What Happens If I Do Nothing?
If you do nothing, you will not receive any payment. You will still be bound by the settlement and give up your right to sue Mylan separately over the same claims. To be eligible for your share of the $60 million, you must file a claim by July 10, 2026.Case Information
Caption: In re Mylan, N.V. Securities Litigation, Master File No. 2:20-cv-00955-NR
Court: U.S. District Court for the Western District of Pennsylvania
Judge: Hon. J. Nicholas Ranjan
Settlement Fund: $60,000,000
Estimated Per Share: ~$0.11 (before fees)
Defendants: Mylan N.V., Heather Bresch (CEO), Rajiv Malik (President), Kenneth Parks (CFO)
Lead Plaintiff: Public Employees' Retirement System of Mississippi (MissPERS)
Lead Counsel: Bernstein Litowitz Berger & Grossmann LLP; Kessler Topaz Meltzer & Check, LLP
Attorney Fees: Up to 25% of the settlement fund (~$15M)
Litigation Expenses: Up to $500,000
Claims Administrator: JND Legal Administration
Claim: Securities fraud — false and misleading statements about FDA inspections and regulatory compliance at Mylan manufacturing facilities
How Do I Find Class Action Settlements?
Find all the latest class actions you can qualify for by getting notified of new lawsuits as soon as they are open to claims:Official Settlement Notice (PDF)
Settlement Website: Mylan2026SecuritiesSettlement.com
File Your Claim
Sources
• Official Settlement Website — Mylan2026SecuritiesSettlement.com• Court-authorized class notice, In re Mylan, N.V. Securities Litigation, Master File No. 2:20-cv-00955-NR (W.D. Pa.)
Filing Class Action Settlement Claims
Please note that your claim form will be rejected if you submit a settlement claim with any fraudulent information. By providing this information and your sworn statement of its veracity, you agree to do so under the penalty of perjury. If you are not sure whether you qualify, visit the class action administrator's website or call 1-866-910-1314. OpenClassActions.com is a consumer advocacy and class action news site, and is not a class action administrator or a law firm.
For more class actions keep scrolling below.
Childrens' Video Game Addiction
Deadline: Pending
Submit Claim
DraftKings & FanDuel Addiction Lawsuits
Status: Open
Submit Claim
Kids Playing Roblox - Alleged Abuse
Pre-Qualify Here
Submit Claim
$990K Differin Acne Product Settlement
Deadline: May 19, 2026
Submit Claim
$4.17M RevitaLash Conditioner Settlement
Deadline: April 20, 2026
Submit Claim
$87.5M Beef Prices Settlement
Deadline: June 30, 2026
Submit Claim
Dollar General Bait & Switch Settlement
Deadline: April 13, 2026
Submit Claim
Belkin Power Bank Settlement
Deadline: March 30, 2026
Submit Claim
Cosequin Dog Supplements Settlement
Deadline: July 21, 2026
Submit Claim
Depo Provera Investigation
Deadline: Pending
Pre-Qualify| Mylan Securities Settlement Summary | |
| Status | Open — Accepting Claims |
|---|---|
| Claim Deadline | July 10, 2026 |
| Settlement Fund | $60,000,000 |
| Estimated Per Share | ~$0.11 (before fees) |
| Who Qualifies | Investors who bought Mylan stock (MYL) Feb 16, 2016 – May 7, 2019 |
| Proof Required | Yes — brokerage statements or trade confirmations |
| Case | In re Mylan, N.V. Securities Litigation, No. 2:20-cv-00955 (W.D. Pa.) |
| Hearing | June 15, 2026 at 10:00 AM ET (Zoom) |
| Website | Mylan 2026 Securities Settlement |